Jan 15, 2019PRESS RELEASESHit 4694
In accordance with section 4 of Korean commercial sale of goods Act 418 MedPacto, Inc board of directions have decided to raise share capital by issuing 83,332 shares through a third-party allotment.
January 15 2019
|Next||[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe|
|Previous||Keytruda Combination Trial Application Approval followed by Another Approval for the Vactosertib + Durvalumab Combination Trial Application|